The excessive activation of JAK and its associated JAK/STAT signaling promotes cancer hallmarks such as proliferation, survival, and angiogenesis, in both the tumor and its surrounding environment, through the activation of STAT3, IL-6, IL-11, IL-22, IL-23, and interferon-γ (IFN-γ) [158]. The gene discussed is STAT3; the disease is cancer.